-
Have you applied for Expanded Access for an experimental treatment?
“Expanded access (or “compassionate use”) gives people access to investigational drugs under certain conditions outside of a clinical trial. The FDA always prefers that people participate in a clinical trial first to ensure they truly have no other options.”
There are a number of treatments in the pipeline, and some look promising. Therapies and treatments such as Tofersen (targeting SOD1 mutations), NurOwn, AMX0035, NU-9, Ravulizumab-cwvz.
Do you know of other treatments and if they target a specific ALS population? Has your doctor applied for Expanded Access on your behalf? Have you inquired about experimental treatments?
What are your thoughts?
Log in to reply.